Showing results (61-70 of 342) with videos related to
Sort By:
Pageof 35
Chemical & Pharmaceutical Bulletin|February 5, 2019
Preparation of Cocoa Powder-Containing Orally Disintegrating Tablets of Rebamipide (Rebamipide Chocolet) and Evaluation of Their Clinical PalatabilityHidehito Takano, Shinya Uchida, Yasuharu Kashiwagura, et al.Cancer Chemotherapy and Pharmacology|April 2, 2016
Changes in cross-sectional area of pulmonary vessels on chest computed tomography after chemotherapy in patients with advanced non-squamous non-small-cell lung cancerMasato Karayama, Naoki Inui, Hideki Kusagaya, et al.Journal of Pharmacological Sciences|March 24, 2019
Effect of co-administered inducer or inhibitor on omeprazole pharmacokinetics based on CYP2C19 genotypeChiaki Kamiya, Naoki Inui, Akio Hakamata, et al.Radiology|May 8, 2009
Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantificationTomohiro Uto, Yasuo Takehara, Yutaro Nakamura, et al.Respiratory Research|June 27, 2018
Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosisShinpei Kato, Naoki Inui, Akio Hakamata, et al.Plos One|September 30, 2015
Synergistic Proinflammatory Responses by IL-17A and Toll-Like Receptor 3 in Human Airway Epithelial CellsKazutaka Mori, Tomoyuki Fujisawa, Hideki Kusagaya, et al.Pulmonary Pharmacology & Therapeutics|April 16, 2013
Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthmaTaisuke Akamatsu, Toshihiro Shirai, Masato Kato, et al.Respirology (Carlton, Vic.)|August 30, 2017
Body size-adjusted dose analysis of pirfenidone in patients with interstitial pneumoniaMasahiro Uehara, Noriyuki Enomoto, Yoshiyuki Oyama, et al.Respiratory Investigation|March 10, 2017
Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseasesTomoyuki Fujisawa, Hironao Hozumi, Masato Kono, et al.The Journal of Rheumatology|May 17, 2019
Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung DiseaseTomoyuki Fujisawa, Hironao Hozumi, Hideki Yasui, et al.Pageof 35